EMEA Recommends Orphan Drug Designation for AX200 for the Treatment of Amyotrophic Lateral Sclerosis
HEIDELBERG, Germany, February 14 /PRNewswire/ -- SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard), today announced that it has received a positive recommendation from the…